Atai Life Sciences Revenue 2020-2025 | ATAI

Atai Life Sciences revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Atai Life Sciences Annual Revenue
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $20
2020 $0
2019 $0
Atai Life Sciences Quarterly Revenue
(Millions of US $)
2025-03-31 $2
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31
2021-12-31 $0
2021-09-30 $0
2021-06-30
2021-03-31 $20
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.497B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.031B 19.74
Encompass Health (EHC) United States $12.013B 25.47
DaVita (DVA) United States $10.339B 14.54
Chemed (CHE) United States $8.026B 25.23
Elanco Animal Health (ELAN) United States $6.685B 14.32
Option Care Health (OPCH) United States $5.163B 23.01
RadNet (RDNT) United States $4.144B 263.00
Amedisys (AMED) United States $3.199B 21.51
Addus HomeCare (ADUS) United States $2.094B 22.99
LifeStance Health (LFST) United States $1.878B 0.00
Astrana Health (ASTH) United States $1.345B 33.33
U.S Physical Therapy (USPH) United States $1.128B 29.13
Pennant (PNTG) United States $0.958B 35.17
Aveanna Healthcare Holdings (AVAH) United States $0.921B 52.44
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.042B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00